logosecondary_white (1)


Mind Medicine Inc.

Mind Medicine (MindMed) Inc. is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. The Company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including psilocybin, LSD, MDMA, DMT and an ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to MindMed’s approach to developing the next generation of psychedelic-inspired medicines and therapies.

Nasdaq: MNMD
IR Website: https://mindmed.co/investor-resources/
Headquarters: New York, NY

Content provided by Mind Medicine Inc. on 2-21-22.


The Mind Medicine Inc. management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.


Press Release / Library

Investor Presentation

Stock Chart 2.0

Stock Detail

SEC Filings

Management Overview

Risks & Disclosures